http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#Head http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#assertion http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#provenance http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#pubinfo http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#assertion http://purl.obolibrary.org/obo/MONDO_0005146 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/MONDO_0005146 http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://go.drugbank.com/drugs/DB01221 http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#association http://www.w3.org/2000/01/rdf-schema#label The most commonly reported diagnosis treated was Major Depressive Disorder (72.2%), followed by Bipolar Disorder (15.1%), and Posttraumatic Stress Disorder (5.7%). Most providers (87.7%) reported administering ketamine via an intravenous route, with a minority reporting using an oral (22.8%) or an intranasal (19.3%) formulation. http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#association https://w3id.org/biolink/vocab/has_population_context http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#cohort http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#association https://w3id.org/biolink/vocab/publications https://pubmed.ncbi.nlm.nih.gov/28669202/ http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/OffLabelIndication http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#cohort http://www.w3.org/2000/01/rdf-schema#label Adults http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#cohort https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Cohort https://go.drugbank.com/drugs/DB01221 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#provenance http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#pubinfo http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#sig http://purl.org/nanopub/x/hasSignature WH66EBsnd4zOO1bx41pXZ3m1X0NAuyd8VYukTK7n1HS6FwCiSvgUCH9SHtB+1kg8sD+PpaZsalHT45SZNno4GqaEkTfCl6vkKZ2Uu7hmZO/rMqsKPaFwF3Oo9HStTeswegs06TyzPgaPwzfVhoznPmBfhPgfxRQ6+8vXpbQ+9+E= http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM http://purl.org/dc/terms/created 2021-05-25T14:42:02.095+02:00 http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM http://purl.org/dc/terms/creator https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAZdZj78B6nKrP1Q00oFzsK07u7WdiY3sToz-H-H2nSgg